| Literature DB >> 26203267 |
Abstract
Acne vulgaris, an epidemic inflammatory skin disease of adolescence, is closely related to Western diet. Three major food classes that promote acne are: 1) hyperglycemic carbohydrates, 2) milk and dairy products, 3) saturated fats including trans-fats and deficient ω-3 polyunsaturated fatty acids (PUFAs). Diet-induced insulin/insulin-like growth factor (IGF-1)-signaling is superimposed on elevated IGF-1 levels during puberty, thereby unmasking the impact of aberrant nutrigenomics on sebaceous gland homeostasis. Western diet provides abundant branched-chain amino acids (BCAAs), glutamine, and palmitic acid. Insulin and IGF-1 suppress the activity of the metabolic transcription factor forkhead box O1 (FoxO1). Insulin, IGF-1, BCAAs, glutamine, and palmitate activate the nutrient-sensitive kinase mechanistic target of rapamycin complex 1 (mTORC1), the key regulator of anabolism and lipogenesis. FoxO1 is a negative coregulator of androgen receptor, peroxisome proliferator-activated receptor-γ (PPARγ), liver X receptor-α, and sterol response element binding protein-1c (SREBP-1c), crucial transcription factors of sebaceous lipogenesis. mTORC1 stimulates the expression of PPARγ and SREBP-1c, promoting sebum production. SREBP-1c upregulates stearoyl-CoA- and Δ6-desaturase, enhancing the proportion of monounsaturated fatty acids in sebum triglycerides. Diet-mediated aberrations in sebum quantity (hyperseborrhea) and composition (dysseborrhea) promote Propionibacterium acnes overgrowth and biofilm formation with overexpression of the virulence factor triglyceride lipase increasing follicular levels of free palmitate and oleate. Free palmitate functions as a "danger signal," stimulating toll-like receptor-2-mediated inflammasome activation with interleukin-1β release, Th17 differentiation, and interleukin-17-mediated keratinocyte proliferation. Oleate stimulates P. acnes adhesion, keratinocyte proliferation, and comedogenesis via interleukin-1α release. Thus, diet-induced metabolomic alterations promote the visible sebofollicular inflammasomopathy acne vulgaris. Nutrition therapy of acne has to increase FoxO1 and to attenuate mTORC1/SREBP-1c signaling. Patients should balance total calorie uptake and restrict refined carbohydrates, milk, dairy protein supplements, saturated fats, and trans-fats. A paleolithic-like diet enriched in vegetables and fish is recommended. Plant-derived mTORC1 inhibitors and ω-3-PUFAs are promising dietary supplements supporting nutrition therapy of acne vulgaris.Entities:
Keywords: acne; comedogenesis; diet; inflammasome; metabolomics; quorum sensing
Year: 2015 PMID: 26203267 PMCID: PMC4507494 DOI: 10.2147/CCID.S69135
Source DB: PubMed Journal: Clin Cosmet Investig Dermatol ISSN: 1178-7015
Figure 1Acne vulgaris: a Western diet-induced sebofollicular inflammasomopathy.
Abbreviations: IGF-1, insulin-like growth factor 1; BCAAs, branched-chain amino acids; miR21, microRNA-21; FoxO1, forkhead box class O1; mTORC1, mechanistic target of rapamycin complex 1; AR, androgen receptor; PPARγ, peroxisome proliferator-activated receptor-γ; LXRα, liver X receptor-α; SREBP1c, sterol response element binding protein 1c; Δ6D, Δ6-desaturase; SCD, stearoyl-CoA desaturase; TG, triglyceride; P. acnes, Propionibacterium acnes; QS, quorum sensing; C16:0, palmitic acid; C18:1, oleic acid; TLR2, toll-like receptor 2; NLRP3, Nod-like receptor family, pyrin domain containing 3 inflammasome; IL-1β, interleukin-1β; Th17, Th17 T-cell; IL-17, interleukin-17, IL-1α, interleukin-1α.
Acneigenic food components of Western diet
| Nutrients | Metabolic and nutrigenomic effects | Sources |
|---|---|---|
| Hyperglycemic carbohydrates | Postprandial hyperinsulinemia | Sugar |
| Insulin-mediated hepatic IGF-1 synthesis | Sweets | |
| Reduction of IGFBP3 | Soft drinks | |
| Increased bioavailability of free circulating IGF-1 | Pizza | |
| Reduction of SHBG | Pasta | |
| Increased bioavailability of free circulating testosterone | Wheat bread | |
| Reduced nuclear activity of FoxO1 | Wheat rolls | |
| Increased expression of sebocyte SREBP-1c | Cornflakes | |
| Activation of mTORC1 | ||
| Glucose-mediated microRNA-21 expression | ||
| Milk and dairy products | Postprandial hyperinsulinemia | Whole and skim milk |
| Increased levels of circulating IGF-1 | Pasteurized fresh milk | |
| Leucine-mediated activation of mTORC1 | Yogurt | |
| Glutamine-mediated activation of mTORC1 | Ice cream | |
| Palmitate-mediated activation of mTORC1 | Whey and casein supplements | |
| Milk-microRNA-21-mediated proliferation and inflammation | Cheese | |
| Saturated fats | Palmitate-mediated activation of mTORC1 | Butter |
| Palmitate-driven inflammasome activation | Cream | |
| Possible mTORC1 activation | Fast food | |
| Proinflammatory signaling | French fries |
Abbreviations: IGF-1, insulin-like growth factor 1; IGFBP3, IGF binding protein 3; SHBG, sex hormone binding globulin; FoxO1, forkhead box O1; SREBP-1c, sterol response element binding protein 1c; mTORC1, mechanistic target of rapamycin complex 1.
Paleolithic-type diet for the nutrition therapy of acne
| Nutrients | Metabolic effects | Sources |
|---|---|---|
| Carbohydrates with low glycemic index | Reduced insulin signaling | Salads |
| Reduction of free IGF-1 | Vegetables | |
| Increase of IGFBP3 und SHBG | ||
| Increase of nuclear FoxO1 | ||
| Reduction of SREBP-1c | ||
| Attenuation of mTORC1 | ||
| ω-3-fatty acids(docosahexaenoic acid and eicosapentaenoic acid) | Inhibition of mTORC1 | Sea fish ω-3-fatty acid-containing oils |
| Inhibition of SREBP-1c | ||
| Reduction of proinflammatory | ||
| eicosanoids (LTB4, PGE2) | ||
| Inhibition of NRLP3 | ||
| inflammasome activation | ||
| Plant products and spices enriched in natural mTORC1 inhibitors and FoxO1 enhancers | Inhibition of mTORC1 | Green tea (EGCG) |
| Activation of nuclear FoxO1 | ||
| Inhibition of | Berries (resveratrol) |
Abbreviations: IGF-1, insulin-like growth factor 1; IGFBP3, IGF binding protein 3; SHBG, sex hormone binding globulin; FoxO1, forkhead box O1; SREBP-1c, sterol response element binding protein 1c; mTORC1, mechanistic target of rapamycin complex 1; LTB4, leukotriene B4; PGE2, prostaglandin E2; EGCG, epigallocatechin-3-gallate.